# Gladstone Capital Corp: overview GLAD · Nasdaq · CIK 1143513 · [Other](/sectors/other.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/glad.md) · [Financials](/companies/glad/financials.md) · [Filings](/companies/glad/filings.md) · [Insiders](/companies/glad/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | [0.50](/filings/0001143513-25-000005.md) | [0.50](/filings/0001143513-25-000008.md) | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-09-30) | FY (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.79](/filings/0001143513-23-000013.md) | [1.88](/filings/0001143513-24-000011.md) | [2.20](/filings/0001143513-24-000011.md) | [2.11](/filings/0001143513-24-000011.md) | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/glad/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $8.9m | 456,227 | | Added +129,881 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $5.6m | 286,863 | | Added +30,684 | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $3.5m | 182,091 | | Added +6,363 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $3.2m | 162,633 | | Added +12,349 | | [B. Riley Wealth Advisors, Inc.](/funds/1464811.md) | 2026-06-30 | $2.6m | 135,581 | | Added +47,286 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $2.4m | 121,639 | | Added +8,349 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.1m | 108,974 | | Reduced −26,606 | | [North Ground Capital](/funds/2055446.md) | 2026-06-30 | $2.0m | 105,280 | | Reduced −37,616 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $1.9m | 97,486 | | Reduced −15,421 | | [Legacy Capital Wealth Partners, LLC](/funds/1766228.md) | 2026-06-30 | $1.7m | 89,112 | | Added +21,005 | ## Recent filings [All 688 filings](/companies/glad/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-01 | 16:06 ET | [8-K](/filings/0001193125-26-410659.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-410659 | | 2026-08-04 | 16:15 ET | [8-K](/filings/0001193125-26-332851.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332851 | | 2026-08-04 | 16:03 ET | [10-Q](/filings/0001143513-26-000012.md) | Quarterly report, period 2026-06-30 | 0001143513-26-000012 | | 2026-06-05 | 16:05 ET | [8-K](/filings/0001193125-26-259535.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-259535 | | 2026-06-02 | 08:45 ET | [8-K](/filings/0001193125-26-252617.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-252617 | | 2026-05-06 | 16:18 ET | [8-K](/filings/0001193125-26-209037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-209037 | | 2026-05-06 | 16:02 ET | [10-Q](/filings/0001143513-26-000009.md) | Quarterly report, period 2026-03-31 | 0001143513-26-000009 | | 2026-03-23 | 08:48 ET | [8-K](/filings/0001193125-26-118675.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-118675 | | 2026-02-05 | 16:01 ET | [8-K](/filings/0001193125-26-039346.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-039346 | | 2026-02-04 | 16:36 ET | [8-K](/filings/0001193125-26-037714.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-037714 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001143513-25-000015.md), filed Nov 17, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1143513 - Tickers: GLAD - Exchange: Nasdaq - SIC code: not reported - State of incorporation: MD - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:17 ET. No prices; not investment advice.